by Chi Wai So, and Michael L. Cleary

Slides:



Advertisements
Similar presentations
Figure 8. Subcellular localisation of murine and human nuclear forms in fusion with EGFP in NIH 3T3 and HeLa cells. Ung2EGFP in NIH 3T3 (A) and HeLa (B)
Advertisements

Volume 6, Issue 6, Pages (December 2004)
The ETS factor TEL2 is a hematopoietic oncoprotein
MgcRacGAP is involved in the control of growth and differentiation of hematopoietic cells by Toshiyuki Kawashima, Koichi Hirose, Takaya Satoh, Azusa Kaneko,
Implications of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome/acute myeloid leukemia by Hironori.
Volume 90, Issue 1, Pages (July 1997)
by Shawn W. Cochrane, Ying Zhao, Robert S. Welner, and Xiao-Hong Sun
The C/EBPδ tumor suppressor is silenced by hypermethylation in acute myeloid leukemia by Shuchi Agrawal, Wolf-Karsten Hofmann, Nicola Tidow, Mathias Ehrich,
Activation of the Erythropoietin Receptor Is Not Required for Internalization of Bound Erythropoietin by Diana L. Beckman, Lilie L. Lin, Mary E. Quinones,
Takashi Tanaka, Michelle A. Soriano, Michael J. Grusby  Immunity 
Leukemia initiated by PMLRARα: the PML domain plays a critical role while retinoic acid–mediated transactivation is dispensable by Scott C. Kogan, Suk-hyun.
by Kevin Oakley, Yufen Han, Bandana A
RELT, a new member of the tumor necrosis factor receptor superfamily, is selectively expressed in hematopoietic tissues and activates transcription factor.
Differential influence of tyrosine residues of the common receptor β subunit on multiple signals induced by human GM-CSF  Tohru Itoh, PhD, Rui Liu, MSc,
In Vivo Expression of Murine Platelet Glycoprotein Ibα
MLL leukemia induction by t(9;11) chromosomal translocation in human hematopoietic stem cells using genome editing by Corina Schneidawind, Johan Jeong,
by Xiaowu Zhang, and Ruibao Ren
Growth Disturbance in Fetal Liver Hematopoiesis of Mll-Mutant Mice
The Anemic Friend Virus gp55 Envelope Protein Induces Erythroid Differentiation in Fetal Liver Colony-Forming Units-Erythroid by Stefan N. Constantinescu,
by Parisa Asvadi, Zohra Ahmadi, and Beng H. Chong
by Hyung-Gyoon Kim, Kyoko Kojima, C. Scott Swindle, Claudiu V
PRMT1 interacts with AML1-ETO to promote its transcriptional activation and progenitor cell proliferative potential by Wei-Jong Shia, Akiko J. Okumura,
Lack of the adhesion molecules P-selectin and intercellular adhesion molecule-1 accelerate the development of BCR/ABL-induced chronic myeloid leukemia-like.
by Hiroyuki Kawagoe, and Gerard C. Grosveld
Attenuation of AML1-ETO cellular dysregulation correlates with increased leukemogenic potential by Russell C. DeKelver, Ming Yan, Eun-Young Ahn, Wei-Jong.
High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia by.
Transcriptional activities of c-MYB and A-MYB fusion proteins.
by Kwang-Hyun Baek, Michelle A
ROG, Repressor of GATA, Regulates the Expression of Cytokine Genes
Distinct classes of c-Kit–activating mutations differ in their ability to promote RUNX1-ETO–associated acute myeloid leukemia by Heidi J. Nick, Hyung-Gyoon.
FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant.
hDOT1L Links Histone Methylation to Leukemogenesis
Volume 29, Issue 1, Pages (January 2016)
Volume 28, Issue 2, Pages (August 2015)
Volume 1, Issue 1, Pages (February 2002)
Acquisition of Oncogenic Potential by RAR Chimeras in Acute Promyelocytic Leukemia through Formation of Homodimers  Richard J Lin, Ronald M Evans  Molecular.
M.Brandon Parrott, Michael A. Barry  Molecular Therapy 
Volume 8, Issue 6, Pages (June 2011)
Ras Induces Mediator Complex Exchange on C/EBPβ
Expression of the MOZ-TIF2 oncoprotein in mice represses senescence
Volume 23, Issue 4, Pages (April 2015)
Volume 12, Issue 2, Pages (August 2003)
lin-35 and lin-53, Two Genes that Antagonize a C
EB3 Regulates Microtubule Dynamics at the Cell Cortex and Is Required for Myoblast Elongation and Fusion  Anne Straube, Andreas Merdes  Current Biology 
HoxB4 Confers Definitive Lymphoid-Myeloid Engraftment Potential on Embryonic Stem Cell and Yolk Sac Hematopoietic Progenitors  Michael Kyba, Rita C.R.
Colin Kwok, Bernd B. Zeisig, Shuo Dong, Chi Wai Eric So  Cancer Cell 
Volume 6, Issue 5, Pages (May 1997)
Characterization of Tfrc-mutant mice with microcytic phenotypes
Volume 6, Issue 5, Pages (May 1997)
Volume 105, Issue 5, Pages (June 2001)
Halofuginone, an Inhibitor of Type-I Collagen Synthesis and Skin Sclerosis, Blocks Transforming-Growth-Factor-β-Mediated Smad3 Activation in Fibroblasts 
Tim C.P. Somervaille, Michael L. Cleary  Cancer Cell 
ROG, Repressor of GATA, Regulates the Expression of Cytokine Genes
Hhex induces promyelocyte self-renewal and cooperates with growth factor independence to cause myeloid leukemia in mice by Jacob T. Jackson, Ashley P.
Volume 14, Issue 2, Pages (February 2001)
Deletion of PREPL, a Gene Encoding a Putative Serine Oligopeptidase, in Patients with Hypotonia-Cystinuria Syndrome  Jaak Jaeken, Kevin Martens, Inge.
Volume 12, Issue 1, Pages (July 2007)
Analyses of the Effects That Disease-Causing Missense Mutations Have on the Structure and Function of the Winged-Helix Protein FOXC1  Ramsey A. Saleem,
Volume 3, Issue 2, Pages (February 2003)
Transcriptional Control of SLC26A4 Is Involved in Pendred Syndrome and Nonsyndromic Enlargement of Vestibular Aqueduct (DFNB4)  Tao Yang, Hilmar Vidarsson,
Akihiko Yokoyama, Michael L. Cleary  Cancer Cell 
Volume 17, Issue 4, Pages (October 2015)
Fig. 2 PRC1 activity is required for leukemic cell growth independently of p16 and p19 expression. PRC1 activity is required for leukemic cell growth independently.
Volume 17, Issue 6, Pages (June 2010)
SUR-8, a Conserved Ras-Binding Protein with Leucine-Rich Repeats, Positively Regulates Ras-Mediated Signaling in C. elegans  Derek S Sieburth, Qun Sun,
Volume 21, Issue 4, Pages (April 2013)
Volume 33, Issue 1, Pages (July 2010)
Chi Wai So, Min Lin, Paul M Ayton, Everett H Chen, Michael L Cleary 
Control of B Cell Production by the Adaptor Protein Lnk
Volume 17, Issue 2, Pages (February 2009)
Presentation transcript:

by Chi Wai So, and Michael L. Cleary Common mechanism for oncogenic activation of MLL by forkhead family proteins by Chi Wai So, and Michael L. Cleary Blood Volume 101(2):633-639 January 15, 2003 ©2003 by American Society of Hematology

Forced expression of MLL-FKHRL1 immortalizes murine myeloid progenitors.(A) Schematic diagram of MLL-FKHRL1 and the retroviral constructs used in transduction/transplantation assays (left). Forced expression of MLL-FKHRL1 immortalizes murine myeloid progenitors.(A) Schematic diagram of MLL-FKHRL1 and the retroviral constructs used in transduction/transplantation assays (left). Conserved motifs in MLL-FKHRL1 include the DNA methyltransferase homology region (MTase), AT hook DBD (AT hook), forkhead DBD (FK), conserved region 2 (CR2), which contains 3 α helices shown as thin vertical bars, and conserved region 3 (CR3). Bar graph (right) shows numbers of colonies obtained after each round of plating in methylcellulose (average of 3 independent assays). (B) Typical morphology of colonies generated at third plating of bone marrow cells transduced with retroviruses expressing the indicated constructs (original magnification, × 100). (C) Phenotypic analysis of cells immortalized by MLL-FKHRL1. Gray histograms represent FACS staining obtained with antibodies specific for the indicated cell surface antigens. Black lines represent staining obtained with isotype control antibodies. Chi Wai So, and Michael L. Cleary Blood 2003;101:633-639 ©2003 by American Society of Hematology

MLL-FKHRL1–immortalized cells induce acute leukemias with latencies similar to MLL-AFX.(A) Survival curves are shown for cohorts (n = 10) of sublethally irradiated C57BL/6 mice that were injected with MLL-FKHRL1–, MLL-AFX–, or MLL-AF10–immortalized cells or... MLL-FKHRL1–immortalized cells induce acute leukemias with latencies similar to MLL-AFX.(A) Survival curves are shown for cohorts (n = 10) of sublethally irradiated C57BL/6 mice that were injected with MLL-FKHRL1–, MLL-AFX–, or MLL-AF10–immortalized cells or saline injected (control) mice. Differences in survival were statistically significant for MLL-FKHRL1 compared to control (P < .018) and MLL-AF10 (P < .008) cohorts but not for MLL-AFX cohort (P < .299). (B) Representative histology is shown for control and MLL-FKHRL1 mice. Leukemic blasts are present in the peripheral blood and infiltrate the portal veins of liver of moribund MLL-FKHRL1 mice (original magnification, × 400). Blood smears were stained with May-Grünwald-Giemsa; paraffin sections were stained with hematoxylin and eosin (original magnification, × 200). Chi Wai So, and Michael L. Cleary Blood 2003;101:633-639 ©2003 by American Society of Hematology

Structural and functional conservation of transcriptional domains in mammalian FKHR family proteins.(A) Schematic diagram showing the conserved domains and sequence alignments of mammalian FKHR family proteins and their C elegans ortholog Daf-16. Structural and functional conservation of transcriptional domains in mammalian FKHR family proteins.(A) Schematic diagram showing the conserved domains and sequence alignments of mammalian FKHR family proteins and their C elegans ortholog Daf-16. CR3 is highly acidic and conserved in all mammalian and nematode orthologs. CR2 consists of 3 conserved helical structures, which are absent in Daf-16. Dark and light shadings represent identical residues and conserved residues, respectively. S and T represent the conserved serine and threonine phosphorylation residues, respectively. H indicates the minimal predicted α helical secondary structures conserved in all mammalian homologs. (B) Transient transfection assays. Schematic diagram (left) illustrates the conserved general structure of mammalian FKHR family proteins. Arrow indicates the site of fusion with MLL. Solid horizontal black lines indicate portions of FKHR or FKHRL1 fused to the Gal4-DBD for transactivation assays. Broken horizontal line indicates the full-length Daf-16a1 fusion with Gal4-DBD. Gal4-AF10 encodes the AF10 sequence (amino acids 682-1085) present in MLL-AF10. Normalized luciferase values are shown (right) for the average of 3 experiments using a reporter gene under control of the HSV-TK promoter. Similar results were obtained on reporter constructs containing the adenoviral E1b or myelomonocytic growth factor receptor promoters (not shown). Comparable expression levels of the Gal4 constructs were confirmed by Western blot analysis (data not shown). Chi Wai So, and Michael L. Cleary Blood 2003;101:633-639 ©2003 by American Society of Hematology

CR2 and CR3 are consistently required for immortalization of myeloid progenitors by MLL-forkhead fusion proteins.(A) Deletion mutants used for hematopoietic transformation assays are shown schematically on the left. CR2 and CR3 are consistently required for immortalization of myeloid progenitors by MLL-forkhead fusion proteins.(A) Deletion mutants used for hematopoietic transformation assays are shown schematically on the left. Bar graph (right) indicates the number of colonies generated by the respective constructs in serial replating assays (means ± SDs, n = 3). (B) Western blot analysis demonstrating expression of MLL fusion constructs identified above the respective gel lanes. (C) Phenotypic analysis of cells transduced by MLL-FKHR. Gray histograms represent FACS staining obtained with antibodies specific for the indicated cell surface antigens. Black lines represent staining obtained with isotype control antibodies. Chi Wai So, and Michael L. Cleary Blood 2003;101:633-639 ©2003 by American Society of Hematology